You need to enable JavaScript to run this app.
FDA shifts classification of some ophthalmic products to comply with Genus decision
Regulatory News
Jeff Craven
Combination Products
North America
OTC
Regulatory NewsJeff Craven
Combination ProductsNorth AmericaOTCRegulatory NewsJeff CravenCombination ProductsNorth AmericaOTC